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Tiivistelmä 
Kinetiikka ja sitoutumismittaukset ovat usein keskeisen tärkeitä 
biolääketieteeseen liittyvässä tutkimuksessa ja teollisuudessa. Erittäin 
herkkää ja ilman leima-aineita tehtävää pintaplasmoniresonanssiin (SPR) 
perustuvaa biosensoritekniikkaa on käytetty vakiintuneena menetelmänä 
biomolekulaariseen analyysiin. Multiparametrinen plasmoniresonanssi (MP-
SPR) laajentaa sitoutumisanalytiikan soveltamismahdollisuuksia ja tarjoaa 
uusia liiketoimintamahdollisuuksia. Kehittyneiden 
regenerointiominaisuuksien soveltamismahdollisuudet luovat merkittävää 
kilpailu-etua. Lisäksi mahdollisuudet kasvattaa liikevoittoja 
biosensorimarkkinoilla ovat lisääntyneet. Bioteknologian ja terveysalojen 
kannattavuus paranee yhdistämällä dataa ja analytiikkaa yhdessä teknologian 
ja liiketoiminnan kanssa. 
Tässä työssä käytetyt kultapäällystetyt sensoripinnat olivat biotinyloituja ja 
muunneltu tiolijohdannaisilla. Sensoreiden optimaalista toimintaa tutkittiin 
regeneroinnin, säilytysolosuhteiden ja ikääntymisen suhteen. Muunneltujen 
pintojen ominaisuuksia ja laatua tutkittiin BioNavis –yhtiön MP-SPR 
laitteella. Switchavidiini valittiin tutkittavaksi molekyyliksi sen suotuisien 
ominaisuuksien vuoksi. Switchavidiinilla on esimerkiksi kyky sitoa 
reversiibelisti biotiinia ja se soveltuu hyvin biosensorisovelluksiin. 
Immunoglobuliini G (IgG) valittiin tähän tutkimukseen, sillä vasta-aine on 
tyypillinen tutkimuksessa käytetty väline. Biosensorimarkkinoita tutkittiin 
markkinoiden tarpeiden ymmärryksen kehittämiseksi, BioNavis -yrityksen 
kilpailukyvyn vahvistamiseksi sekä liiketoimintamahdollisuuksien 
kasvattamiseksi. Tässä tutkielmassa pyrittiin lisäämään ymmärrystä tieteen ja 
kaupallisuuden välisestä yhteydestä sekä hyödyntämään tutkimustuloksia 
liiketoiminnan edistämisessä.  
Sensoreiden regeneroituvuus säilyi hyvin ja BioNavis voi käyttää 
tutkimuksen tuloksia myynnissä ja markkinoinnissa. Tulosten avulla voidaan 
vahvistaa regenerointiprosessin toimivuus ja sensoreille optimaaliset 
olosuhteet. Sensoreiden käyttöajan ja säilyvyyden arviointi edellyttää 
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lisätutkimusta. Lisäksi erillinen sensorit ja reagenssit sisältävä pakkaus voisi 
tuoda lisäarvoa yritykselle. Kokeiden tulokset ja havainnot antavat 
hyödyllistä tietoa jatkotutkimukselle. Tulosten avulla voidaan lisä-optimoida 
ja tehdä jatkotutkimuksia, jotka mahdollistavat innovatiivisia liiketoiminta 
strategioita ja kehittää olemassa olevien asiakkuuksien arvoa. Tämä Pro 
Gradu työ korostaa biolääketieteen, teknologian ja liiketoiminnan yhteistyön 
tärkeyttä yritysten ja akateemisen sektorin välillä. 
Avainsanat: pintaplasmoinresonanssi, biosensori, multiparametrinen 
pintaplasmoniresonanssi, diagnostiikka, switchavidin, biotinyloidut 
sensoripinnat, liiketoimintamalli, strategia, innovaatio, kaupallistaminen, 
regeneraatio, asiakaslähtöisyys, regeneroitavuus, kultapäällysteiset 
sensoripinnat 
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Abstract 
Kinetics and binding measurements are often inevitable in biomedicine 
related research and industry. The highly sensitive and label free surface 
plasmon resonance (SPR) biosensor method has been used as an established 
method for biomolecular analysis. Multi-Parametric Surface Plasmon 
Resonance (MP-SPR) broadens the application range for interaction analyses 
and offers new insights for growing business markets. Enhanced regeneration 
capabilities would create significant competitive advantage possibilities for 
various applications. In addition, possibilities to gain revenues in the 
biosensor related markets have been growing.  At the forefront of biotech and 
health related sectors, profitability is often made by combining data, analytics 
with technology and business. 
In this thesis gold coated sensor slide surfaces were biotinylated and modified 
with thiol derivatives to examine the optimal functionality of sensors in terms 
of regeneration, storage circumstances and aging. The characteristics and 
quality of the modified surfaces were investigated with BioNavis multi 
parametric surface plasmon resonance (MP-SPR) device. Switchavidin was 
selected for injections because of its remarkable properties and ability to bind 
reversible to biotin. Immunoglobulin G (IgG) was chosen because the 
antibody is a relevant and widely used molecular tool. Biosensor related bio 
business aspects were studied in order to characterize market economy and 
understand universal needs to create business opportunities in order to grow 
revenues. Features related for attaining and maintaining competitiveness in 
biosensor related markets were studied. In addition, the results accomplished 
in this Master’s Thesis work, was aimed to gather additional information for 
BioNavis in order to enhance further business strategies. Biobusiness 
orientation was highlighted through the Thesis in order to advance translation 
of research results to industry and provide understanding about the 
relationships between science, technology, development and business. 
Sensor slides regenerated surprisingly good and BioNavis can use the results 
as a part of the material in selling and marketing. The functional regeneration 
process and features for sensor slide’s optimal environment can be confirmed 
with the results. Aging and shelf life estimation needs further research in 
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order to gain more specific results but provides an agenda for further research. 
Additionally, the kit could bring further value for the company. The results 
and observations made from the experiments provide useful data for the 
further research. Additionally, further optimization and studies can be made 
with results in order to innovate new business strategy interventions and build 
cross-sell services. This Master’s Thesis advocates further cooperation on 
biomedical science, technology and business among enterprises and academic 
sector. 
Keywords: surface plasmon resonance, biosensor, multi parametric surface 
plasmon resonance, diagnostics, switchavidin, biotinylated sensor slides, 
business model, strategy, innovation, commercialization, customer focus, 
regeneration, gold coated sensor slides 
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1 INTRODUCTION 
Biosensors provide sophisticated technology for quantitative and qualitative analysis 
of interaction. Biosensor related markets have been growing rapidly (Patching 2014; 
Vigneshvar et al. 2016). Surface plasmon resonance (SPR) makes real-time analysis 
possible and sensitivity is high in optical based SPR devices. New ways have been 
discovered to immobilize analytes with polymers or nanomaterials in order to improve 
both detection limit and sensitivity of SPR (Patching 2014; Vigneshvar et al. 2016). 
Yet, sensor slides with both desired surface properties and appropriate bulk properties 
are challenging to manufacture (Holzinger et al. 2014; Paladiya and Kiani 2018). Most 
of the challenges are related with the long-term usage of sensor slides and discoveries 
for better sensor regeneration technologies are needed. Especially from the biosensor 
markets point of view, competitive advantage can be created by enhancing these 
properties (Vigneshvar et al. 2016). Additionally, in medical and biotechnological 
related research and industry, reduction or prevention of undesired biofouling is 
necessary. Sensor slides may go through diverse of circumstances and environments 
that are affecting to the aging process and shelf life. The aim of this Master’s Thesis 
was to study the functionality of biotin-coated sensor slides in combination with 
switchavidin (Taskinen et al. 2014) and their commercial potential. This thesis work 
represents co-operative work between the Faculty of Medicine and Life Sciences and 
BioNavis Ltd. in order to advance science and translation of research results to industry 
and business. Important part of the study was to research and evaluate profoundly what 
are the optimal circumstances to achieve optimal regeneration cycles in order to 
advance competitiveness of BioNavis products in the biosensor related markets. The 
surface chemistry of all the gold coated and biotinylated sensor slides was the same 
but the storage conditions were different from each other. Altogether four different 
environments were studied. Each environment had two adjacent sensor slides, 
respectively. Additionally, one 100 cycle measurement was made to study the 
regeneration capacity over extended measurement. Measurements were made by using 
MP-SPR Navi™ 420A ILVES instrument. Altogether nine sensor slides were included 
in the final analysis. The results of the analysis supported the MP-SPR instrument 
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combined with the optimal sensor slides as a reliable and valid measurement 
technology. 
Improved regeneration process attributes can provide significant value for business. 
The present market research studies have been suggested that in the near future surface 
plasmon resonance related innovations will be even more significant in the field of 
medicine and pharma. Furthermore, biosensors can be used widely e.g. in the 
environment, security, defense and food safety areas (Deng 2017; Turner 2013; 
Vigneshvar et al. 2016). In particular, even though biomolecular interactions have been 
studied decades based on surface plasmon resonance, developments in the field of 
biosensor technology may provide e.g. significant enhancement for portable 
technologies in the near future. This includes the important themes about personalized 
medicine, a lab on a chip (LOC) and point of care (POC) devices (Nguyen et al. 2015; 
Zanchetta et al. 2017). Scientific substance knowledge is supporting the Thesis’s 
business orientation and customer-focused approach. Furthermore, post-marketing 
studies can be made based on the results obtained here. 
Regeneration was a specific objective in this research because the challenges related 
to this process have been recognized universally. However, the events and properties 
that are determining the regeneration process details, are deeply complex. Aging 
process and shelf life were additional objectives. Surface related characteristics e.g. 
chemical and physical properties as well as the topographies are defining surface 
mechanics and functionalization that are affecting to aging processes and shelf life 
(Guegan et al. 2014; Tallawi et al. 2015; Yang et al. 2014).  Biosensors are broadly 
utilized and the markets are globally promising. For instance, Grand View Research 
(2017) have demonstrated that especially optical based biosensors have one of the most 
fastest growing future perspectives. Chapters addresses the multidisciplinary entities 
and focuses on business policy and other measures necessary to enhance 
competitiveness. The cumulative technical and business based continuous learning 
was achieved during the work.  
In this thesis gold coated sensor slide surfaces were modified with coatings consisting 
of biotin-thiol derivatives in order to achieve optimal functionality and fouling 
properties. Functionality assessment included regeneration process studies and aging 
process studies. Switchavidin and biotinylated immunoglobulin G were selected to be 
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immobilized on the biotin surface. The role of switchavidin is established as one of the 
most optimal tool for biosensor applications and immunoglobulin G is relevant model 
molecule to use in the second attached layer. At first, in the review of the literature 
section, the SPR and MP-SPR are represented with emphasis on physical aspects and 
assay design insights. Sensor slides and factors affecting the surface fouling are 
discussed, with a focus on the main characteristics of the research. The review of the 
literature section is also representing the diversity of the factors affecting bio business 
with emphasis on biosensor related markets. Potential inventions may not be 
succeeded without a solid business plan and this topic is discussed. Specifically, the 
aspects of commercial marketing benefits are regarded. Later, the experimental setup 
and results are represented. Finally, comprehensive discussion and conclusion are 
combining the most significant scientific and business-related findings made in this 
thesis work. 
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2 LITERATURE REVIEW  
2.1 Biosensors and surface plasmon resonance  
According to International Union of Pure and Applied Chemistry (IUPAC), biosensor 
can be defined as a device that can detect chemical compounds. Turner et al. (1987) 
defined biosensor as an analytical device with sensing element that incorporates with 
physiochemical transduces (Turner et al. 1987; Thevenot et al. 1999; Wang W. et al. 
2017). Clark and Lyons (1962) described biosensors at a New York Academy of 
Sciences symposium as sensors incorporating with biological material. One of the first 
enzyme related transducers were then introduced by Clark and Lyons (Clark and Lyons 
1962). Surface plasmon resonance biosensing is highly sensitive and label-free 
technique. Transduction mechanism of biosensor devices are based e.g. on optical, 
thermal or electrical signals. Surface plasmon resonance is based on optical detection 
(Homola et al. 1999; Ozkan-Ariksoyal 2013; Thevenot et al. 1999). The measurement 
technology has been developed based on the biotechnological multidisciplinary work 
that combines life sciences and engineering. For example, Carrara (2010) describes 
about how interactions of a laser beam with metallic surface have been studied already 
in 1960s. The quantum phenomenon of surface plasmon resonance was discovered 
already then and many applications have been made in the rapidly growing area of 
research after the discovery. Sensing technique development have been rapid. Systems 
that are based on a real-time measurement techniques have specific detection methods 
for analyte detection. Biotechnological advances have been providing wide range of 
novel biochemical materials with advanced properties (Bosch et al. 2007; Plaxco and 
Soh 2011, Wilson and Hu 2000). 
Besides the real-time monitoring, one of the advantages is the sensitivity of the surface 
plasmon resonance measurement systems. Nanoparticles and nanostructure usage and 
development can provide even more sensitive measurement technology methods 
(Mayer and Hafner 2011). New techniques provide possibilities to make long-term 
experiments with cells in order to permit cell survival. Cellular responses of the living 
cells can be monitored in real-time (Vigneshvar et al. 2016; Viitala et al. 2013). 
Simultaneous multiple analyte detection is relevant in order to make better applications 
e.g. to measure protein interactions (Heeres and Hergenrother 2011) or screen and 
detect toxins (Brennan et al. 2012). While proteins can be immobilized to the sensor 
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slide surface via adsorption to study protein-protein interactions, it is also possible to 
use biosensors to get dynamic response information about living cell behavior and 
investigate long-term changes. The surface of the sensor slide must be chemically 
functionalized in order to detect only the target-analytes that bind to the surface. 
Modern SPR instruments enable multiple detection of the analytes simultaneously 
when usually challenges may emerge with only one output channel (Cetin et al. 2014; 
Dong et al. 2008). In general, both industry and academia can use biosensors in a wide 
scale. Interest towards biosensors has grown in many different areas such as 
environment, medical sciences and military field. Biosensors can be used e.g. in drug 
discovery for validation, concentration management or target identification (Grand 
View Research 2017, Ronkainen et al. 2010). 
2.1.1 MP-SPR 
Multi-parametric surface plasmon resonance (MP-SPR) is based on real-time and label 
free measurement technique like the normal SPR but MP-SPR provides a different 
optical setup. Both can be used to detect and analyze biomolecular interactions 
(Lakayan et al. 2018; Sonny et al. 2010). MP-SPR system enables i.e. real-time angular 
scanning with variable wavelength. Additionally, biosensing can be optimized with 
the selection of the sensor surface material. Surface plasmon resonance is highly 
sensitive and fast technique (Lakayan et al. 2018; Sonny et al. 2010). Multiparametric 
surface plasmon resonance (MP-SPR) devices offer modern technology for molecular 
interaction studies. Multi fluidic channel systems for high throughput need 
measurements with modern software offers platform to make advanced assay design. 
MP-SPR instruments are good options e.g. for surface interaction studies and 
nanolayer characterization (Kari et al. 2017; Korhonen et al. 2015; Viitala et al. 2013). 
Additionally, MP-SPR is offering insights for controlled drug release and cell and 
tissue engineering. MP-SPR can be combined with electrochemistry and catalytic 
interactions can be measured (BioNavis 2017; Kari et al. 2017; Korhonen et al. 2015; 
Grieshaber et al. 2008). Table 1 is describing more specifically the comprehensive 
possibilities that MP-SPR have in life sciences, material sciences and biosensor related 
assay development and point of care (POC) biosensor development. Table 2 is 
highlighting the parameters the can be measured only with MP-SPR (BioNavis 2017; 
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Grieshaber et al. 2008; Kari et al. 2017; Korhonen et al. 2015; Lakayan et al. 2018; 
Viitala et al. 2013). 
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Table 1. Application possibilities of the MP-SPR portfolio products. Table is showing some of 
the specific features of the MP-SPR technology. The most important features are introduced 
and highlighted (Modified from BioNavis 2017. Based on Grieshaber et al. 2008; Kari et al. 
2017; Korhonen et al. 2015; Lakayan et al. 2018). 
 
Parameters measured only with 
MP-SPR 
 
Characteristics 
Intensity of SPR peak min  
• in liquid  
• in gas 
• on metals and metal oxides 
• hydrogels 
 
- Sensor material and media are depending 
factors  
(Another wavelength pair) 
*not in device used in these 
measurements 
• Resolving the layer thickness and RI 
 
                   Biosensors                 Life Sciences            Material Sciences 
Assay 
development 
 
Development of point of 
care biosensors 
 
Drug 
development  
 
Biophysics 
 
New materials and 
coatings 
 
Process 
optimization of 
thin film 
manufacturing  
 
 
Agriculture 
Food and feed 
safety 
Environmental 
Clinical 
Border and 
process control 
 
 
EC 
 
SERS 
ELISA 
Fluorescence 
printed 
biosensors 
Nanoparticles 
 
 
Drug 
formulation 
Controlled 
drug release 
Drug-cell 
interaction 
Nanoparticle 
targeting 
Uptake 
mechanisms 
 
 
 
Lipid 
interactions 
 
 
  
Antimicrobial 
Antireflective 
surfaces 
Filter 
membranes 
Contact lenses 
Implants 
Carbon 
nanotubes 
Plasmonic 
materials 
Graphene 
Green materials 
 
 
Display 
technologies 
Solar cells 
Batteries 
 
Features 
 
Different possibilities of sensing substrate 
materials (à variety of markets). 
In-line bulk effect measurement 
Simultaneously possibility to determine 
thickness and refractive index. 
 
Possibility to measure interaction 
kinetics and layer structural 
changes. 
In real-time and label-free 
possibility to distinguish trans- 
and para-cellular 
drug/nanoparticle transport on 
cell monolayer. 
In-line bulk effect measurement. 
 
Commercial SPR for material 
sciences. 
Biochemical properties of 
functional coatings can be studied 
with good sensitivity. 
Alternating nanolaminate thickness 
is possible to measure from 5Å, with 
optical density and its barrier 
functionality. 
Simultaneously possibility to 
determine thickness and refractive 
index. 
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• Possible to use for all measurements 
SPR-width at 3 different levels • Defines the shape of the SPR peak 
 
• Enables absorbing coating and sample 
characterization because the absorption of light 
by the binding molecules is informed 
Steepest falling and raising 
slope 
• The most sensitive measurement area is shown 
 
• For the quick fixed angle measurements 
 
Total Internal Reflection (TIR) 
value 
• Utilized for dn/dc calculations 
 
• Bulk properties around the sensor are 
depending factors 
Table 2. Characteristics of the SPR/MP-SPR technology. Angular position of SPR peak min 
can be measured with both traditional SPR and MP-SPR but the parameters listed here can 
be measured only with MP-SPR (Modified from BioNavis 2017. Based on Grieshaber et al. 
2008; Kari et al. 2017; Korhonen et al. 2015; Lakayan et al. 2018; Viitala et al. 2013). 
2.1.2 Physical aspects 
Plasmons are solutions to Maxwell’s equations that is valid for certain metal-dielectric 
geometries (Maier 2007). The polarization for a metal nanoparticle is enhanced at 
certain frequencies of light. Phenomena is occurring for visible light in noble metals 
(Maier 2007). By the use of subwaveleght structures, the propagation of light can be 
controlled. In science and technology, plasmonics is an emerging area and the 
applications of this phenomena includes SPR sensors (Anwar et al 2017). Common 
plasmonic biosensors are utilizing refractometric detection (Anwar et al 2017; Quinn 
et al. 2000; Špačková et al. 2016; Wang S. et al. 2017). By optical spectroscopy, 
changes in intensity of light for different wavelengths can then be detected.  
Surface plasmon resonance (SPR)-based transducers measures plasmon 
resonance angle change. Angle change can be measured using light which is reflected 
from the sensor slide’s surface. Surface with the immobilized receptors is enabling the 
detection of the binding and release events (Anwar et al 2017; Quinn et al. 2000; 
Špačková et al. 2016; Wang W. et al. 2017). The surface properties of the sensor slides 
can vary a lot. For example, sensor slide can be gold coated with the specific surface 
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chemistry. Wide range of sensor surface materials from inorganic layers (SiO2, TiO2) 
to functionalized sensor surfaces such as carboxymethyldextran (CDM) are available 
(BioNavis 2017; Patching 2014). SPR angle change is growing when the mass that 
bound onto the surface increases (Cooper 2002; Homola 2008). SPR based devices 
can be based on a technology that have an influence on a refractive index change that 
can be monitored (Sonny 2010).  
This thesis introduces shortly the basis on the physical phenomena behind SPR 
biosensing because it is relevant to understand the core science behind the biosensor 
functions. The profound explanation of the physics is left out because the most specific 
focus in this thesis is in the biomedical research related to the bio business aspects. 
2.2 MP-SPR Assay Design and Reagents 
There are many available methods to immobilize bait molecules on biosensor surface. 
In label-free biosensors the detection is based on the reaction where the binding of the 
analyte molecules occurs on the sensing surface (Pollheimer et al. 2013). Sophisticated 
MP-SPR devices includes run table to help to design the assay. Flow setting can be 
adjusted optimally in order to prevent diffusion effects and to reach Langmuir 
behavior. Higher diffusive flux can be reached with small sensors because of the edge 
effects and on the other hand multiple molecules are lost due the flow that reduces 
capture efficiency (Dahlin 2017). 
2.2.1 Switchable mutant of avidin 
Switchavidin is a chicken avidin mutant suitable for manufacturing of regenerable 
functional layers on biosensor surface (Pollheimer et al. 2013; Tallawi et al. 2105 
Taskinen et al. 2014). Avidins are homotetrameric glycoproteins (MW 68 kDa) found 
in egg white with four identical subunits. Avidins are able to bind biotin with high 
affinity (Kd ~ 10-15 M) and specificity. Switchavidin can be used for the reversible 
immobilization of biotinylated sensor surfaces because switchavidin is displaying a 
reversible binding to biotin. Reversibility possibilities are better when attaching 
biotinylated biomolecules to biotinylated substrates via switchavidin bridges 
(Holzinger et al. 2014; Pollheimer et al. 2013). Due the reduced surface charge, 
switchavidin has a low nonspecific binding capacity but an excellent binding affinity 
toward conjugated biotin. Vitamin H is also known as biotin and its MW is 244.3 kDa. 
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The four biotin binding sites of (switch)avidin enable the stable complex formation 
between switchavidin and biotin. (Pollheimer et al. 2013; Tallawi et al. 2105 Taskinen 
et al. 2014). 
Furthermore, this kind of immobilization method enables the reproducibility of the 
biosensoring. The ideal situation is to have a rapid method for the reversible 
immobilization of biotinylated bait molecules on biotinylated sensor slides and 
switchavidin has been used in this thesis work because of these characteristic 
properties (Pollheimer et al. 2013; Tallawi et al. 2105 Taskinen et al. 2014).  
2.2.2 Immunoglobulin G  
The immunoglobulin G (IgG) molecules are produced by the adaptive immune system 
in humans and other vertebrates. These molecules are also called antibodies. 
Antibodies are glycoproteins (Grieshaber et al. 2008; Panda and Ding 2015). In this 
research, selected biotinylated antibody IgG is used as for a verification of the 
biosensor functionalization after every switchavidin injection. Antibodies can bind to 
particular target molecules with excellent specificity and affinity. These properties 
make antibodies suitable for MP-SPR experiments and verification. Antibody 
fragments are also used as a reliable alternative to antibodies (Grieshaber et al. 
2008). Usually antibody consists of two Fab' binding sites and one Fc. Antibody 
fragments are smaller and suitable for biosensor applications. Binding is highly 
specific, even though part of the heavy chains is missing in Fab fragments 
(Grieshaber et al. 2008). Antibodies can be easily engineered and they can recognize 
peptides, proteins and almost any other structures. 
2.2.3 Sodium dodecyl sulfate 
The optimal situation is when biotinylated bait molecules can be immobilized and 
removed as often as needed. There are naturally occurring limit for the time span for 
sensor slides and furthermore for their optimal functionality (Pollheimer et al. 2013; 
Taskinen et al. 2014; Zauner et al. 2016). According to Zauner and co-workers (2016) 
the combination of 0.25% sodium dodecyl sulfate (SDS) and 2.5% citric acid (pH 2) 
can cause the instant cleavage for the bridges that switchavidin and biotin form i.e. 
biotin-avidin-biotin bridges and the same strategy was utilized by Pollheimer et al. 
(2013).  
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2.3 Sensor slides, surface related factors and materials involved in the 
SPR experiments and technology 
2.3.1 Sensor slides and surface architecture - Surface materials and 
modifications.  
SAMs are self-assembled monolayers that present the variety of the polymers that can 
be used on the surfaces of the sensor slides (Chapman et al. 2000; Grieshaber et al. 
2008). Metallic surfaces such as gold can be coated with self-assembled monolayers 
(SAMs) of sulfides (thiols). Highly organized functionalized structures can be 
formed with thiol-containing molecules (Chapman et al. 2000; Grieshaber et al. 
2008). Chemical and physical modifications e.g. grafting and cross-linking have been 
enabling new ways to customize material properties (Benhabbour et al. 2008; Müller 
et al. 2017). The assay design defines what polymers and substrates to use. For 
example, the sensor slide’s surface can be biotinylated using biotin molecules 
conjugated into thiol groups like in this thesis work. Alternatively, direct 
immobilization by covalent derivatization can be made e.g. with aldehyde 
modification or amine coupling (Vachali et al. 2015). Furthermore, because of the 
biotinylated surfaces, the switchavidin was used in this thesis work to form biotin-
avidin bridges, followed by biotinylated IgG for the verification of the avidin 
attachment.  
Reagents and polymers must be carefully chosen. There are multiple ways to 
immobilize ligand on the sensor surface such as using thiol modification. Both 
adsorption and binding events are detected due the changes in the surface plasmon 
waves and in the local index of refraction (Lakayan et al. 2018; Pollheimer et al. 2013; 
Taskinen et al. 2014).  
2.3.2 Surface materials and modifications - Adhesion to gold-coated surfaces  
Gold is the metal that is often used in biosensor technology. Sensor surface needs to 
be conductive and compared to other metals, gold is an inert metal and it does not 
cause toxic side effects (Long et al. 2013; Spivak et al. 2013; Zhang 2010). Nanogold 
and colloidal gold have been considered as one of the most promising biocompatible 
materials for many healthcare applications because of the electronic and tunable 
optical properties. (Long et al. 2013; Spivak et al. 2013; Zhang 2010). Thin layer of 
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gold on the surfaces, approximately 50 nm, is used for supporting the electron 
plasmon. The downside of this metal layer is where the incident laser beams and 
reflected laser beams are controlled. The metal layer`s topside is used to immobilize 
probe antibodies. Furthermore, the topside is utilized for protein and antigen 
interaction studies by using a microfluidic system (Carrara 2010; Ray et al. 2010). This 
thesis focuses on gold plated sensor slides. Besides the research, the specificity of the 
sensor slide’s surface chemistry is related to the commercialization and marketing 
entirety. 
2.3.3 Functionalized sensor slide and the biochemistry 
The functionalized sensor slide is the bio recognition element in surface plasmon 
resonance (Liu et al. 2015). The biotinylated gold surface makes possible that the 
switchavidin can attach to it. Running buffer in flowing through the sensor surface. 
Ligand gets immobilized on the sensor chip and the analyte is flowing through the 
sensor slide surface (Patching 2014; Vachali et al. 2015). 
2.3.4 Biosensors and transducers 
SPR method is providing information about the changes on the sensor surface in real-
time and the signal is transduced into optical response. Different types of biosensors 
have different types of characteristics and application possibilities. There are variety 
of transducers to use in the detection, depending on the application (Grieshaber et al. 
2008; Soper et al. 2006; Tothill 2009). Ideal biosensor can meet many requirements 
like specificity, sensitivity, real-time monitoring possibility with high-throughput 
detection system for multiple analytes and the recording possibilities for reversible 
responses. Biosensors and specifically the transducers can achieve more possibilities 
in one application with the new methods of fabrication techniques. Interdisciplinary 
knowledge from areas such as electrical engineering and bioengineering, medicine, 
quantum, bioelectronics surface physics and biochemistry are required (Grieshaber 
et al. 2008; Soper et al. 2006; Tothill 2009). 
2.4 Data analysis 
Reporting and processing biosensor related data requires a lot of manual performing 
but developed software platforms and tools are helping to interpret big entities of data. 
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Surface plasmon resonance data analysis tools may vary a lot depending on the 
manufacturer. Data analysis is time consuming and high requirements are set. 
Multiparametric data analysis requires robust and accurate responses from surface 
plasmon resonance systems (Dahl et al. 2017). 
2.4.1 Association and dissociation 
Association phase is the first phase when the target analyte is binding (Homola 1999). 
In the next phase molecules are constantly binding to the surface and dissociating from 
it even though binding seems to reach equilibrium and a plateau. Both affinity 
constants and external factors i.e. temperature and buffer composition are affecting to 
binding and dissociating events. The accessible binding sites on the sensor slide 
surface are never fully occupied. This is the stage when the affinity of the analyte-
ligand interaction can be seen (Homola 1999, Homola 2008). Final phase of biosensor 
measurement cycle is typically the dissociation phase (Cooper 2002, Homola 2008).  
In reality, the surface of the sensor is a dynamic system as some binding and 
dissociation is constantly occurring. This needs to be considered already in the assay 
design phase. Injection times, temperature, concentration, buffer composition and all 
the washing steps are meaningful in the assay design. First, when equilibrium is 
reached, the total number of bound molecules can be calculated. Second, the washing 
steps are important for the dissociation phase to become visible (Cooper 2002, Homola 
2008). 
2.4.2 Regeneration process 
Total dissociation of the bound molecules is occurring in the regeneration process as 
described in Picture 1. Regeneration condition selection is delicate as descripted in 
studies made by Pollheimer et al. (2013), Taskinen et al. (2014) and Zauner et al. 
(2016). Regeneration conditions in this thesis were selected based on these studies and 
because of that, the literature of review is underlining these conditions. The phases 
from association to regeneration phase are repeated after the regeneration pulse. After 
every regeneration pulse, the aim is to retain the target molecules (biofunctionalization 
layer) on the surface. In the ideal environment, the original and functionally optimal 
conditions are retained. Some of the biosensor related challenges are associated with 
the regeneration process (Vigneshvar et al. 2016).  
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Figure 1: Full regeneration cycle of biotinylated biosensor surface. Removal of switchavidin 
(5) is a key feature as gold coated biotinylated sensor surfaces can tolerate rigorous 
regeneration cycles. Four binding sites of switchavidin are illustrated (2). The switchavidin 
interaction mechanism towards biotinylated sensor surface (1) and binding of biotinylated 
IgG (3) on it are described in the picture. Modified from Knoglinger et al. (2018). 
2.4.3 Sensor performance and aging process 
Product performance knowledge is useful and important for end users. For example, 
depending on the product, physical stability and kinetic stability can be estimated. The 
shelf life of a sensor slide is depending on many things. In this thesis estimations about 
sensor slides’ shelf life and aging process are made because this information is 
supporting the experimental part’s data analysis. Accelerated aging test can be used in 
order to determine lifespan of product and the tests are made especially for novel 
products to become introduced into market. Accelerated aging test can include e.g. 
heat, oxygen to speed up the normal aging process of sensor slides. Different 
temperatures and humidity conditions can support accelerated aging tests (Maxwell et 
al. 2005). In many cases, packaging information of the product must include and 
provide an assessment of the shelf life. 
2.5 The variety of biosensor applications possibilities  
Specificity in a real-time analysis and low detection limit for analyte detection is 
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important e.g. in a disease diagnosis (Kim et al. 2015). Biosensor applications can 
utilize e.g. a combination of electrochemical sensing and high-throughput biosensors. 
Drug-cell interactions can be monitored in real time with SPR that is a huge advantage 
in the field of drug discovery and development. Furthermore, the measurements can 
be done under constant flow e.g. living cells can be monitored under dynamic 
conditions (Knoglinger et al. 2018; Viitala et al. 2013). Lateral-flow technology is used 
in MP-SPR devices to induce the formation of specific interactions (Kari et al. 2017; 
Liu et al 2015; Viitala et al. 2013). SPR technology provides excellent time resolution 
and it makes possible to report volume changes in living cells attached on the 
biosensor. Cell volume regulation and the changes in it are often very important 
indicators for many cell pathologies.  
MP-SPR is also suitable method for material sciences. It can provide optimization for 
solid films in a wide range from ångströms to 100 nanometers. Kinetic parameters can 
be solved with the SPR technology and its applications (Kari et al. 2017; Liu et al 
2015; Viitala et al. 2013). This means that e.g. Ka and Kd can be estimated with the 
SPR instrument. Different biosensor applications can be used for many purposes in the 
field of medicine. Besides medicine, the markets are wide in the field of environment, 
food safety, defense, agriculture, industry and security. 
2.6 Biosensors and the markets 
There have been continuous advances in biosensor applications and future estimations 
for the markets are great. Picture 2 describes how in April 24, 2018, the S&P 
Biotechnology Select Industry index turned in a 16 percent return from over in a 10-
year period. Total price returns for S&P biotechnology selected industry index as an 
index level from a same period was almost 6.9 units (S&P Down Jones Indices, 2018) 
The index knowledge is relevant for investors. Biosensor markets are valued to be 
27.06 billion dollars in 2022 (Markets and Markets 2017) and according to Report 
Buyer’s market research (Report Buyer 2017) the biosensor markets were estimated 
to be 16.9 billion dollars in 2017. Both international research and industry requires 
reliable products that can offer automatization and cost-effectiveness. Medical and 
health related areas have tremendous markets. There is estimated to be significant 
growth in the non-medical markets as well. Companies are about to make significant 
growth also in such areas as environment, agriculture and food production.  According 
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the governmental initiatives global biosensor markets are expected to accelerate also 
by the development of genomics and proteomics (Grand View Research 2017). 
 
Figure 2. S&P Biotechnology Select Industry Index. S&P Dow Jones Indices. From Jan 27, 2006 to 
Apr 24, 2018. S&P is an American stock market index. It is based on having common stock listed on 
NASDAQ and NYSE by the market capitalizations of 500 large companies (Modified from S&P 
24.4.2018).  The most noticeable is that S&P Biotechnology Select Industry index turned in a 16 percent 
return from over in a 10-year period. 
Biosensor markets can be categorized based on the technology; optical, 
electrochemical, piezoelectric and thermal (Grand View Research 2017; Ozkan-
Ariksoysal 2013). Especially electrochemical biosensor segment markets have been 
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very successful. Many significant applications for quantification and analysis have 
been invented and sold related to the biological and biochemical processes (Grand 
View Research 2017; Ozkan-Ariksoysal 2013) The fastest growing segment is 
excepted to be the optical segment of biosensors. In this light, SPR and MP-SPR 
related applications have very potential future perspectives. The optical sensors have 
multiple application possibilities e.g. related to structural studies, receptor-cell 
interactions studies, kinetic studies, equilibrium studies and concentration studies 
(Grand View Research 2017). 
2.6.1 Commercializing successful biomedical technologies 
Business today is quite turbulent. Standards in health technology and industry have 
raised as well as the standards in the environment and food safety areas. Real impact 
is delivered by having sufficient internal recourses and by creating fast solutions while 
improving the productivity of assets constantly (Turner 2013; Wirtz et al. 2016). 
Success in the bio business field requires interdisciplinary work. A great innovation is 
only rarely enough to gain success in the markets (Dollar and Kraay 2003). Label-free 
biosensors can be developed for various detection methods and wide application 
possibilities can be provided for markets (Citartan et al. 2013; Turner 2013). 
Furthermore, various commercializing possibilities can be created via this basis. 
Commercializing process has its unique power to elevate the innovation and the final 
product to the next level.  People with negotiation skills are needed to close the deals 
and help to gain repeated further purchases. Substance knowledge is important but 
social and emotional intelligence is needed when negotiating deals with the customers. 
Companies have to individualize customers and context. They also need to prescribe 
and deliver the easiest and fastest solutions for the customer needs (Grand View 
Research 2017; Neethirajan et al. 2018). Companies have to be able to improve self-
service tools, troubleshooting, present solutions, resolve issues and customize the 
interaction. Successful commercializing process is big entirety (Nevens et al. 1990; 
Ozkan-Ariksoysal 2013; Sveiby 1997). Navigating company to more profitable future 
is often reflected by the diversity of interdisciplinary team work. Profit oriented 
commercialization processes can provide opportunity for further expansion and 
revenue generation. For example, in the pharma industry aligned medical and 
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commercial actions can be used. Early iterative engagement with payers, providers and 
key opinion leader (KOL) can support market shaping (Sax 2016).  
2.6.2 Translating the technology into success; from lab to business 
Building and sustaining competitive advantage from lab to business can bring 
unexpected challenges. Scale of challenges exists in the strategy formulation, planning 
and business development, also distribution and logistics have their own challenges. 
Furthermore, successful marketing, selling, customer service, sales and account 
management have significant positive impact on earnings (Neethirajan et al. 2018; 
Ozkan-Ariksoysal 2013). Creating a successful route from lab to business means 
revenues that are increasing faster than expenses. And it requires understanding about 
how to mobilize the right resources and not to focus only on short-time results. It is an 
asset to have investors who can recognize if company’s strategy is not working and 
identify investment risks. Value-conscious segmented market thinking is needed in 
business. Costly but ineffective technologies are the worst scenario and it is essential 
to define the end user, customers and understand the customer needs (Nevens et al. 
1990; Pellikka et al. 2012; Thevenot 1999). Laboratory circumstances and easy data 
capture may not always be possible and biosensor applications can offer solutions for 
these issues. It requires a lot to translate the technology into a very successful business; 
from lab to business Nevens et al. 1990; Pellikka et al. 2012; Thevenot 1999) Great 
business intelligence creates more value to increase the cash flow in the range that 
desired and have more revenues.  
2.6.3 Business model – innovation 
A great business model can make a significant difference when multiple innovations 
and products are competing against each other in the markets (Stähler 2002). Real 
advantage possibilities are laying in the marketplace and the business model have to 
offer extensive support for the company (Wintjes 2006; Wirtz et al. 2016). SPR and 
MP-SPR are technology driven-innovations that can offer optimal solutions for the 
customer needs in many ways as demonstrated in Table 1 and Table 2. Yet, markets 
are indicating that even better solutions and business models can be created. Current 
business world is dynamic, demanding a lot multidisciplinary knowledge and skills. In 
the field of biotech products, lots of research and development (R&D) have been done 
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before finalizing the product. Constant resilience is needed all the time. Creating new 
value is important because competitive advantage is not sustainable. Furthermore, this 
indicates towards ideology where strategies and business models needs to be smartly 
updated. (Teece DJ 2010; Wirtz et al. 2016). The heart of the innovations and business 
models are the customers and their needs. Building sustainable long-term client 
relationships in the dynamic business world can be challenging. Balancing between 
risks and opportunities may even lead to difficult strategic decisions (Amit and Zott 
2012; Osterwalder and Pigneur 2005). Finally, a successful biotech business cannot be 
built without great management skills that are the essential core of the business. Great 
management skills are often combination of business intelligence and comprehensive 
substance knowledge (Branstetter et al 2014; Gibbons et al. 2010) e.g. from the field 
of biomedicine, biotechnology and business. 
2.6.4 Product and services 
Different instruments, devices and products are constantly heading to be far more 
sophisticated than before. Lots of R&D is required before finalizing the product and 
developing a knowledge based economy requires adequate levels of investment 
besides R&D (Wintjes 2006). Product improvements and even some new product 
opportunities can be generated while resolving user and client experiences in later 
phases. The most important is to be able to clarify the value of the new product or 
design for the intended user. The biosensor related technology area is really interesting 
regarding the markets. The technology in itself can be really specialized. Yet, there are 
laying great possibilities to attract really wide customer bases from different fields of 
technology and industry. Novel, useful and liable applications in the forefront of health 
industry have really wide customer bases (Grand View Research 2017; Neethirajan et 
al. 2018; Ozkan-Ariksoysal 2013). Biosensor related portable devices, kits and 
services have remarkable potential to create business value. Multiple possibilities in 
more than one technology and industry area will help to increase the connections and 
odds to build long-term success (Wintjes 2006). Besides the product, brilliant software 
can bring significant value for the company. Continuous development is necessary 
because markets are evolving rapidly, especially with data-enhanced products 
(Delgado et al. 2012; Schwab 2017). 
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2.6.5 Regulatory constraints and quality controls in the cycle of 
development 
The awareness of different intellectual property types is needed in the field of bio 
business and it is relevant to make sure to understand what is needed for patent 
procedure. Also in biotech -industry some trade secret may be difficult or even 
challenging to maintain. When it comes to business models and business thinking, it 
is essential to be aware of intellectual property rights and also have knowledge about 
options e.g. licensing agreements and royalties. Manufacturing takes regulatory 
compliance, validation and standards to fulfill (Brunet 2012; Van Norman 2016). 
Device development also takes its own time and needs optimization and design. The 
Food and Drug Administration (FDA) has a significant role i.e. in the drug and device 
approvals as in Europe the marketed medical device must have a Conformité 
Européenne (CE) mark. Tens of notified bodies are operating in EU are there are 
differences in safety, performance and clinical efficiency aspects depending on the 
authorization (Brunet 2012; Van Norman 2016). Additionally, new greater data 
protection regulation (GDPR) is setting some new standards and practices for the 
industry. The scope of GDPR is extensive and compliance policy is strict (European 
Parliament 2016). 
2.6.6 Quality Management System 
A quality management system (QMS) is a collection of business processes. ISO 
(International Organization of Standardization) 9001:2008 was updated to 
ISO9001:2015 because there have been significant changes in business needs and 
expectations (Croasdell 2001; International Organization of Standardization 2015; 
Thevenot 1999). Standards are implementing and maintaining e.g. organizational 
processes, documenting, polices and goals. QMS focuses to improve customer 
satisfaction and align the organization’s strategic direction. Different management 
system standards are harmonized by ISO. QMS is applicable to any size or type of 
organizations. ISO9001:2015 sets out criteria for QMS and it is certifiable. The new 
version of ISO9001 includes separately e.g. product and services section, instead of 
product in order to make services more applicability. Risk-based thinking is introduced 
more profoundly in the new standards in order to adapt it depending on the 
organization or business situation. ISO9001:2015 leadership requirements have 
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increased and integrated management system has opportunity to address elements such 
as environment (Croasdell 2001; International Organization of Standardization 2015; 
Thevenot 1999) QMS principles always includes strong customer focus and according 
to Nevans (2001) “manufacturing quality is marked as one of the key elements that 
would give firms an edge competitively in the market”. Additionally, organizations 
usually have their own standard operation procedures (SOPs). 
2.7 Marketing and sales 
Harvard Business review (2017) highlights the strategic and staggering business 
implications in the year 2017 latest issue. Digitalization and new tools are changing 
the way how enterprises serve customers, train employees, design and create products. 
The ultimately important is how the enterprise can compete in the markets (Porter and 
Heppelmann 2017; West et al. 2010). Innovation and the product are rarely enough, if 
the marketing and sales are lacking the competence. Products are transferred into very 
real business benefits with marketing and sales (West et al. 2010). Right marketing 
strategy is helping to eliminate the geographic distance and the navigation through the 
global challenges in business (Wintjes 2006). It is easier to make substantial 
improvements in quality, productivity, and other measures of performance when there 
is knowledge about the markets, selling and customer needs. Most of the companies 
are struggling at some point in the business with challenges and own specific business 
model is needed to gain the real business benefits (Ozkan-Ariksoysal 2013; Schwab 
2017; Sosna et al. 2010). 
2.7.1 Market analysis 
Market analysis can be used for different purposes like developing the business 
strategy or doing evaluation about the size of markets in overall. Biotech products and 
services can be developed further with the information of the analysis. Up-to-date 
information eases to create more assets to the company in the complex markets (Grand 
View Research 2017; Sveiby 1997). Specialized market research can even reduce the 
financial risks. Sales and trends may change quickly. Comprehensive market condition 
check is also an efficient way to know how to improve customer satisfaction. It can 
even assess new viewpoints to the future markets potential (Markets and Markets 
2017; Sveiby 1997). For example, biosensors can be used in the different fields of 
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technology. Specific customer groups can be approached with the unique way because 
of the market research knowledge. Furthermore, different marketing message can be 
used in sales. Even verbatim comments from the clients can directly have influence on 
the company’s services, sales, product development and customer support activities in 
overall. Specialized market research can be used in overall for many purposes in the field 
of biotech business to reduce the financial risks that are always involved in the processes 
of developing, selling and serving (Markets and Markets 2017).  
2.7.2 Strategy and making the successful market plan 
Strategy delivery is just as important as the design of the product. Commercialization 
of advanced detection methodologies in biosensor area has not been as advanced as 
research output (Ozkan-Ariksoysal 2013; West et al. 2010). Medical science related 
innovations are disciplining the engineering principles to biomedical technologies and 
defined strategy can deliver benefits. Business strategies can be often multiplied in the 
field of technology and services. 
Important is to create functional strategies that really are working. Fast and cost-
effective solutions are needed all the time to the problems that biosensors can solve. 
According to the latest market research results (Grand View Research 2017; Markets 
and Markets 2017; Report Buyer 2017), biosensor related markets are accelerating 
rapidly. According to these studies the compound annual growth rate (CAGR) between 
2017 and 2022 is estimated to reach 8.1%. Significant growth is about to be in the Asia 
Pacific markets with a CAGR of 11.4%. The most significant end-user markets for 
biosensors are estimated to be in the North America. The fastest growing segment is 
excepted to be the optical segment of biosensors (Grand View Research 2017; Markets 
and Markets 2017; Report Buyer 2017). This implicates the importance of making 
finalized strategical decisions in the global markets.  
2.8 Insights about customers and competitors 
The concept that product can be created in a collaboration with the customers is 
relaying on the ideology that customers can give significant insights to help to build 
strong and sustainable relationships. Recent advances in the biosensor technology are 
providing multiple options from electrochemical biosensors to the optic based 
biosensor technology that includes the SPR based instruments (Kim et al. 2015; Wang 
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et al. 2013). For now, glucose monitoring sensors and the pregnancy tests have been 
among the most successful biosensor devices in the markets. There is often correlation 
between some practical ideas that customers have and the ones that will lead to the 
most successful products. Quantitative glucose sensors have been changing the lives 
of diabetes patients (Yao et al. 2011). Qualitative pregnancy tests are based on a lateral 
flow assay in order to detect human chorionic gonadotropin hormone. Achieving 
desired processes have been resulting to improve customer satisfaction further. Both 
of these biosensors have significantly large markets and there has been fundamental 
competition between different company’s products. Neither of product is competing 
straight with e.g. MP-SPR but both are great examples of biosensor related business 
development. The products are representing intelligent strategical commercialization 
process development in the competitive markets (Delgado et al. 2012; Nevens et al. 
1990; Wintjes 2006).  
In the literature, many competitive theories are still based on Porter´s (1990) Diamond 
Model. In the examples above, customer base has not been automatically lost in any 
cases even if competitor may have lower-cost alternatives. This fundamental rule is 
still valid in the business world. Many aspects are affecting to the final decision about 
closing the deal (Eisenhardt 1989). For example, easier data handling with specific 
software can be a deal breaker, rather than the device’s price. Each company has the 
ability to compete while meeting quality goals. Identifying segments of customers with 
similar needs can help to avoid losing any market share. Some governments may also 
have their own role when it comes to protecting and promoting competition (Dosi et 
al. 2015; Wintjes 2006). All stakeholders have important roles when creating real 
competition and changes in the health technology related industry. 
2.8.1 Customer focus 
The field of biosensor technology is dependent on the most fundamental force in 
economics that is the principle of supply and demand. Tailored solutions are good to 
provide to any user problems. Workforce needs to understand and address the needs 
that customer have. Relationships with vendors are also important and the principle to 
bring benefit for all the investors. It is not just about closing the deals but also 
reframing the customer relationships and keep actively extending customer base in 
order to have revenues. It is essential not to depend just on the former sales 
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intermediates which requires the capability to respond changes and not to hold too 
long to any strategy that has been once successful (West et al. 2010). One part of the 
customer focus can be to create anonymous feedback channels and incorporate novel 
information. Explicitly consider some alternative perspectives and strategies. When 
there is a deep market understanding, it is easier to identify and analyze the problems 
and make the most powerful solutions. Organizational capabilities can be always 
developed which increases the level of competence in overall (Salazar et al. 2012; 
Sveiby 1997). Changes are inevitable but they need to be accepted and develop 
organizational capabilities in order to become more profitable. Having the right and 
relevant regulatory and financial expertise can make a tremendous difference in the 
outcomes of the decisions. Most of all market understanding and result orientation is 
needed in the context of the customer focus.  
2.8.2 Competitive advantage 
Competitive advantage is the attribute that is outperforming the company from its 
competitors. Michael Porter defined different forms of generic competitive advantage 
decades ago (Porter 1990). His book is one of the most influential management book 
still on the 20th century. Competitive advantage can be achieved by developing robust 
plans, products, new strategies, promoting, improving and serving the customers better 
that competitors do. Differential strategy and focus strategy may require significantly 
new and creative ways to provide excellent products for different customer segments. 
Cost leadership is one option to gain competitive advantage but it often requires lower-
cost base for materials and facilities (Porter 1985; Porter 1996). 
Besides high-quality products, a company can achieve competitive advantage in e.g. 
with customary post-sales support, kits and other value-adds that can facilitate the use 
and purchases of instruments, devices and supplies. Competitive advantage can be 
achieved specially over those companies who are not making that much effort to 
clarify their customer needs (Liu 2017; Porter 1985). Despite developing and 
implementing the strategies, unexpected challenges may emerge. Achieved 
competitive advance can help to outline the strengths and weaknesses of the current 
situation and ease to make better decisions in the markets (Salazar et al. 2012; West et 
al. 2010). Vice versa; competitive advance is hard to achieve without outlining the 
strengths and weaknesses. Organizations might pursue changes in order to remain 
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competitive and productive while trying to drive down the costs (Salazar et al. 2012; 
West et al. 2010). According to Schwab (2017) there are about to emerge even more 
new strategic ways to create competitive advantage. In this light, more deal-driven 
customers and investors can be attracted in the biotech business field by making new 
and better strategic planning.  
2.9 Business development - Measuring success 
Based on the previous chapters, economic growth is a significant success indicator. 
Customer satisfaction or profitability per district can be success measures (Almquist 
et al. 2018; Bocken et al. 2014; Freeman and Beale 1992). The secondary sector 
business opportunities are really important regarding the business development. New 
business opportunities can be also maximized by developing the long-term customer 
relationships (Almquist et al. 2018, Bocken et al. 2014; Freeman and Beale 1992). 
Some companies are more market-driven than others and number of ways such as 
increased awareness or strategic partnerships can be also used as success indicators. 
Ultimately, company should be worthy by all stakeholders. 
2.10 State of art and future perspectives 
In the forefront of science there is always a need for the new analysis methods that are 
delivering more cost-effective solutions for the problems related to human health end 
environment. Future perspectives are covering the application possibilities from 
medical research and clinical use to the wide market areas of industry. Biosensor 
technology is expected to achieve even more sophisticated possibilities in one 
application due the new methods of fabrication techniques (Tothill 2009; Soper et al. 
2006). Advances in microbead and layer-by-layer techniques are expected to develop 
innovations more towards 3D biosensors (Dias 2014; Vigneshvar et al. 2016). Patient-
specific treatments are expected to develop even further when disease screening and 
clinical diagnosis methods are improved based on the multiple analyte detection 
(Tothill 2009; Vigneshvar et al. 2016). Major rapid advances have been already made 
in recent years. For example, significant detection limit and sensitivity improvements 
have been made by using right polymers or nanomaterials in the analyte immobilizing 
process (Wang et al. 2013). Point of care technology is the state of the art in many 
innovations. According to the Report Buyer´s Market research (2017), the largest 
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application area for the biosensors is excepted to be the POC testing. The markets are 
great for the portable devices. MP-SPR is a suitable method for point of care 
applications in assay development. The label-free platform is providing robust and 
quick tool for preclinical use (Kari et al. 2017). Especially there has been development 
in the surface plasmon resonance imaging (SPRi) detection. This powerful technology 
may be the most promising technique that will ultimately improve point of care testing 
and lab on a chip (LOC) technology (Puiu and Bala 2016). Furthermore, future 
applications can offer more sophisticated biosensors e.g. for almost every stage, that 
are included in the drug discovery processes. Portability and novel technologies are 
making more and more possibilities to achieve competitive advantage in the biosensor 
markets (Grand View Research, 2017). Cell survival is possible under some 
measurements techniques and new possibilities for in vivo measurements are expected 
(Dias 2014; Vigneshvar et al. 2016). Markets are wide for robust regenerative 
biosensors. Customers have need for long-term use in the field of diagnostic, drug 
discovery, environment, agriculture, food industry, security and defense (Citartan et 
al. 2013; Fracchiolla et al. 2013). Semiconductor materials and quantum dot 
technology have also significant potential for applications (Peng et al. 2014; Shen et 
al. 2014). Optic-based biosensors are expected to offer significant technology 
application solutions in biosensing. Fiber-optic techniques have possibilities to enable 
even more variety to transducers (Kwon and Bard, 2012). Advances in biosensing and 
biofabrication are together allowing powerful application possibilities for fast growing 
markets (Dias 2014; Vigneshvar et al. 2016). 
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3 AIMS OF STUDY 
The aim of this thesis was to design SPR assay for MP-SPR Navi™ 420A ILVES 
instrument. In the assay the regeneration processes of biotin-coated sensor slides were 
studied. The specific focus was to characterize different sensor slides in different 
storage conditions. This process also included more specific aims that are listed below:  
I  Research biotinylated sensor slides’ ability to bind switchavidin after different 
storage conditions and capability of the bound switchavidin to bind IgG. 
II  Research and interpret aging and shelf life of biotin-coated sensor slides. 
III Research regeneration abilities of gold coated sensor slides in order to give insights 
for the preparation of business and marketing material. 
IV Translate scientific results into business opportunities 
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4 MATERIALS AND METHODS 
4.1 Materials  
Switchavidin protein was dissolved in water and 2.5ml aliquots were made in 50 µg/ml 
concentration and stored in in -20 °C. Switchavidin was originally produced, purified, 
characterized and lyophilized by the Protein Dynamics research group in the Faculty 
of Medicine and Life Sciences in the University of Tampere. For every run a new 
aliquot was taken from the freezer (-20 °C) approximately 20 minutes before the 
injections. Biotinylated immunoglobulin G was ordered from Jackson Immuno 
Research Laboratories, INC. Baltimore, USA. This protein was Biotin-SP-conjugated 
AffiniPure Bovine Anti-Goat IgG (H+L) with minimal cross-reaction to bovine, 
chicken, guinea pig, syrian hamster, horse, human, mouse, rabbit and rat serum 
proteins. IgG was delivered in volume of 0.5 ml and antibody concentration was 1.6 
mg/ml. IgG was dissolved in the filtrated buffer that was 50 mM sodium phosphate, 
150 mM NaCl, pH 7.2. The final concentration for IgG was 1µg/ml. Aliquots were 
made for extended storage after rehydration and stored in -20 °C. The number of 
aliquots in the whole research was estimated and calculated by the need of the 
injections. New IgG aliquot was taken from the fridge (-20 °C) approximately 20 
minutes before the injections. The running buffer in the measurements was phosphate 
buffered saline (PBS) and its pH was adjusted in 7.3 with concentrated HCl. 
Regeneration solution was citric acid 2.5% + SDS 0.25% (pH 2.1). Wash solution 
contained SDS 0.5 %. 3 minutes hellmanex (Sigma-Aldrich Z805939 – 1EA, 
HellmanexTM III, Lot 2728318) 2% injections were used between sensor slide changes. 
Used storage bottles were H2O2 treated in the fume hood before making the solutions. 
Device was connected beforehand so that the temperature between the device and all 
reagents would be equal when the measurement were about to begin. The device 
temperature was set in 22 °C. 96-well plate format was used for the switchavidin, 
antibody IgG and hellmanex injections. SDS 0.5% and citric acid 2.5% with SDS 
0.25% was injected from the 50ml polypropylene tubes that were placed in the sidewall 
of the device. Needle height was set in 1 mm and run table was filled before every 
measurement. All measurements were made with the BioNavis MP-SPR Navis™ 
420A ILVES instrument. Gold plated sensor slides were made by Martin Albers from 
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BioNavis (Tampere, Finland). Sensor slides were biotinylated using a company´s own 
protocol.  
4.1.1 Sensor slides and assay design 
Thin glass slides were coated with a 50-nm thin gold layer. Sensor slides used in this 
Masters’ Thesis were manufactured together with Dr. Albers (Bionavis Ltd.) because 
the gold coated sensor slides and their biotin coating surface chemistry is a business 
secret of the company. Sensor slides were stored in four different conditions that were 
+4 ° C, RT (room temperature), +30 °C and humid conditions in RT. In every 
environment two different sensor slides were used for parallel measurements 
respectively (sensor slide 1 and sensor slide 2). Measurements in the first part of the 
research were repeated every week in scheduled timescale precisely in all 
environments. Measurements in the long measurement entirety were made with one 
sensor slide (sensor slide 1) and repeated in different timescale than in the first part of 
the research. The overall assay design is demonstrated in the Table 3 and in the Table 
4 comprehensively. After finishing the measurements with a sensor slide, it was placed 
back to its storage environment in a shell. Measurement days are not equal in all 
environments because the timing of measurement days had to exact and some 
preference had to be made because there were four different environments with two 
sensors in each to measure. The amount of antibody IgG was highly limited which is 
why it was not injected after every switchavidin injection.  
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Circumstance +4 °C RT RT Humid +30 °C 
Sensor slides Sensor Slide 1,  
Sensor Slide 2 
Sensor Slide 1,  
Sensor Slide 2 
Sensor Slide 1,  
Sensor Slide 2 
Sensor Slide 1,  
Sensor Slide 2 
Days/Switchavidin 14 14 10 12 
Days/IgG 12 12 10 12 
Measurement cycles  4  4  4  4 
Total measurement 
cycles 
28 28 20 24 
Total IgG injections 18 18 14 18 
Total Switchavidin 
injections 
14 14 10 12 
Table 3. Measurements entity 1. Measurements in different storage conditions. Sensor slides 
and their storage conditions. The timing and the total number of switchavidin and IgG 
injections are demonstrated. 
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Table 4. Measurement entity 2. 100 cycles measurement with one sensor slide. Storage 
condition +4 °C. The timing and total number of switchavidin and IgG injections are 
demonstrated. 
4.1.2 Injection protocol 
For each measurement injection parameters and running actions were set in the MP-
SPR Navi Control – Autosampler Run table. Injection flow rate was 30 µl/min for each 
sample. The average of the flow channels was calculated after exporting the data from 
Trace Drawer (BioNavis) to Excel. Figure 3 and Figure 4 are demonstrating the 
injections and injection protocol. The specific regeneration evaluation was based on 
the baseline change analyzation (R=IV-I) that is demonstrated in the Figure 4. 
Injection volume for switchavidin and IgG were 300 µl. Injection volume for SDS 
0.5% and citric acid 2.5% with SDS 0.25% were 462 µl. Running buffer (PBS) flow 
was in pre-injection delays for all samples 2 minutes and post injection delays 5 
minutes. Running buffer was automatically flowing through between every injection. 
Injection length for switchavidin and IgG were 6 minutes. Injection length for SDS 
Circumstance +4 °C 
Sensor Slides Sensor Slide 1 
Days 5 
Measurement cycles/day 20 
Total measurement cycles 100 
IgG injections Day 1 Injections 1, 7,14, 20 
Day 2 Injections 7,14, 20 
Day 3 Injections 7,14, 20 
Day 4 Injections 7,14, 20 
Day 5 Injections 1, 7,14, 20 
 
Switchavidin injections Day 1 Injections 1-20 
Day 2 Injections 1-20 
Day 3 Injections 1-20 
Day 4 Injections 1-20 
Day 5 Injections 1-20 
 
Total IgG injections 17 
Total Switchavidin injections 100 
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0.5% and citric acid 2.5% with SDS 0.25% were 3 minutes. Every measurement cycle 
started with SDS 0.5%. Measurement cycles consisting of (1) citric acid 2.5% with 
SDS 0.25% (2) switchavidin and (3) biotinylated antibody injection are demonstrated 
in the Figure 3 and Figure 4. The cycle was repeated four times for each sensor slide 
in different environments. Furthermore, one specific assay was made with one sensor 
slide that was stored in +4 ℃ if the measurement was not active (during nights) for 
five days. Sensor slide were left in +4 ℃ for further studies. Same cycle for this sensor 
slide was repeated 100 times. 
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Figure 3. Biosensor measurement protocol. 3a is demonstrating the injection protocol. The 
cycle entirety was repeated four times for each sensor slide stored in different environments. 
One measurement cycle is consisting of (1) citric acid 2.5% with SDS 0.25% (2) switchavidin, 
(3) biotinylated antibody injection and running buffer PBS. 3b is showing a part of the 100 
cycle measurement injections that were made during one day. 100 cycle measurement was 
made with one sensor slide. Same cycle entirety was repeated 100 times for this sensor slide 
as described in 1a. Data is illustrated by MP-SPR Navi™ Control software. 
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Figure 4: The injections from one measurement cycle. Intervals I-IV are demonstrating the 
time points of flow channel averages. I = baseline, II = determined total switchavidin binding 
after wash, III = determined total IgG binding after wash, IV = baseline. R (IV-I) corresponds 
to the baseline change. It characterizes the regeneration performance. Data is viewed by 
Trace Drawer™ after processing and exporting it from MP-SPR Navi™ Data Viewer. 
4.1.3 SPR experiments and device control  
Flow cell was opened and sensor slide was inserted in its place between prism and 
elastomer. Flow cell was closed and “Initializing Scan” (Init. scan) was selected and 
executed. Different procedures e.g. “wash all and kick the bubble” were needed if the 
SPR peak in the init. scan wasn`t good enough. After respectable results, angular scan 
was made. Liquid range was selected for both measurements respectively. 
Measurements were made in high refractive index media so that the angle of incidence 
was between 50-78 degrees. Experiment was started only after all the parameters were 
detailed. Each experiment started with baseline measurement that took approximately 
8 to 15 minutes for each run. Hellmanex (2%) injection (300 µl/min, 5 minutes) from 
the well plate was done between experiments with different sensor slides. 
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4.2 Data analysis 
Measured data was first analyzed in the MP-SPR Navi™ Control and exported into 
MP-SPR Navi™ Data Viewer. Degrees were changed in mDeg after exporting the 
measured from the MP-SPR Navi™ Control and MP-SPR Navi™ Data Viewer into 
Trace Drawer™ and every flow channel was layered according the channel, injection 
and day. For advanced analysis data was exported to Trace Drawer™ where the data 
was layered by different flow channels, injections and days. After Trace Drawer 
analysis, the data was exported to the Excel for the final calculations and analysis. In 
Excel, an average from every injections’ different flow channels were calculated. 
  
36 
 
 
 
5   RESULTS 
5.1 Performance of the biosensor surface stored in different             
environments 
5.1.1 Biotinylated sensor’s ability to bind switchavidin and sensor’s 
performance after storage 
Biotinylated sensor slides were found to bind switchavidin differently depending on 
the storage conditions. Switchavidin is attaching onto sensor slide’s surface like 
Pollheimer et al. (2013) and Zauner et al. (2016) have published in their work (Figure 
5 and Figure 8).  
As can be seen from Figure 5, almost all sensor slides are showing clear decrease in 
switchavidin binding when the measurement days are about to reach 8 to 12 days. 
However, in humid conditions, there are no significant drop observed after such 
storage time. Both of the biotinylated sensors stored in humid conditions have 
switchavidin binding capacity values above 300 mDeg during the whole measurement 
protocol. Additionally, both sensor slide 1 and sensor slide 2 are performing the most 
equal fashion as compared to the sensors stored in other conditions. 
Room temperature conditions have the most descending linear change in switchavidin 
binding values and days 8-12 are indicating slightly weakening capacity to bind 
switchavidin (Figure 5). The breakdown of the sensor slides in +30 °C can be seen 
already in day 8 and the measured response is only slightly above 100 mDeg (Figure 
5). For the sensors stored at +4 °C, there aren`t significant decrease observed in the 
measured response in day 8 or after two weeks (Figure 5). The switchavidin binding 
values in +4 °C are varying most if compared to other environments. Sensor 2 have 
slightly higher values than sensor slide 1 expect in day 10. Overall, +4 °C and RT 
humid show the best performance over time but the binding signal measured using 
slides stored at +4 °C are much lower than those observed for slides stored at RT in 
humid conditions. The values in RT humid environments are constantly above 300 
mDeg and even close to 350 mDeg during the whole measurements. 
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Different biotin functionalization trials were made for the gold surfaces using different 
reagents and the fresh reagents seemed to yield the most optimal functionalization. 
This might be one interesting point of view to research more in order to manufacture 
even better sensor slides. Overall there appeared to be no significant differences 
between the qualities of the parallel sensor slides in different environments. Only a 
few significant deviations can be seen such as temperature + 30 °C in day 8 (injection 
1) is statistically deviant. In environment RT, the sensor slide 1 has the most deviant 
values from the sensor slide 2. Yet, differences are rather small regarding the scaling 
is in mDeg. 
Figure 5. Switchavidin binding on biotinylated sensor stored in different conditions. Binding 
of switchavidin has been measured using two parallel sensors, and four measurement cycles 
were carried out. (a) sensor stored at +4°C (b) sensor stored at +30°C RT, (c) sensor stored 
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at RT, (d) sensor stored in humid conditions at RT. Please note that only one sensor was 
analyzed for the day 2 in the case of sensor stored at +30°C (b) and in the case of the day 14 
for sensor stored at RT (d). 
5.1.2 Capability of switchavidin to bind IgG after different storage conditions 
The cycles shown in Figure 6 are demonstrating the verification that was made by 
using the antibody IgG. Until day 4, all the sensor slides and environments are showing 
a ratio of IgG/Switchavidin close to 1.5 (Figure 7). The ratio is prominently good in 
all environments during the whole measurements even in the highest temperature but 
a little unexpected variation can be seen in the RT environment. The results are 
indicating that after two weeks the binding capacity of the bound switchavidin layer is 
not collapsed. It is challenging to extrapolate how different environments would 
performance after 3 weeks. Nonetheless, RT humid environment is showing the most 
promising results as can be seen in every D graphs, respectively.  
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Figure 6. Switchavidin performance to bind IgG after different environmental storage 
conditions. Effects of binding are measured and demonstrated in environments 4°C, 30°C, RT, 
and RT Humid. 
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Figure 7. Ratio of IgG/Switchavidin binding for sensors with different storage conditions. 
Demonstration of IgG/Switchavidin ratio are measured in environments 4°C, 30°C, RT, and 
RT Humid. 
Interestingly mere RT environment or +4°C environment isn’t indicating as good 
results as expected as seen in graphs A and C, if compared to D graphs in Figure 6 and 
Figure 7. It was expected that +30 °C environment is about to set too harsh conditions 
for biotin-functionalized gold sensor slides but it was interesting to observe the time 
point when the sensor slides were about to diminish their optimal performance. As 
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seen in every B graphs, the sensor slides in the highest temperature are about to break 
between day 4 and day 8.  
Nonetheless, the collected data show that switchavidin binding was occurring and 
verification with IgG seemed to function rather well. Next step could be to continue 
measurements until 3-4 weeks to see how the binding capacity is about to start to 
decrease.  
Knoglinger and co-workers (2018) reported about transferring biotinylated sensor 
slide into argon filled Falcon™ tube that was stored at +4 °C. This might be a good 
method to use in the future experiments. Even though the data is in mDeg, the 
deviations in +4 °C environment are the quite significant as results in the 5.1 - 5.3 are 
demonstrating. According to Knoglinger et al. (2018), the +4°C temperature should be 
relatively good choice for storage conditions. 
Additionally, the repeated removal of IgG and switchavidin after each IgG injection, 
that was performed with mixture of citric acid 2.5% and SDS 0.25%, seemed to 
remove proteins rather good. Typical another choice for e.g. antigen removal can be 
performed with 100 mM glycine buffer (pH 2.7, GE Healthcare Data File 18-1012-91 
AC, as Pollheimer et al. (2013) was performed in their research. Nonetheless, 
Pollheimer et al. also reported in their article in 2013, about how the instantaneous 
cleavage of the biotin-avidin-biotin bridges can be caused by citric acid 2.5% and SDS 
0.25% combination.  
5.2 100 cycles measurement 
Binding and desorption of switchavidin was repeated with good reproducibility in 100 
cycles measurement, as illustrated in the Figure 8 and Figure 9. As the results shows, 
the study design was successful and reliable. Results are indicating that the gold coated 
biotinylated sensor slide can have great ability for complete regeneration cycles. Yet, 
further measurements are needed to give more information about the specific storage 
conditions but the sensor slide accomplished the goal to regenerate. Results are 
representing comprehensive and steady average of the flow cells as mentioned in the 
materials and methods. Significant deviations are indicating also about possible 
disturbances as air bubbles in one flow cell channel. This is why the average of three 
flow channels have been calculated instead of one flow cell channel. The average was 
42 
 
 
calculated in order to minimize bias that could have occurred if only one flow channel 
was observed for the analyzes.  
 
Figure 8. Biotinylated sensor slide’s ability to bind switchavidin. 100 measurement cycles are 
shown. This 100 cycles measurement study was conducted in 5 days. Measurement was active 
24/7. Only reagents (switchavidin and IgG) were changed between the days.  
 
Figure 9. Capability of immobilized switchavidin to bind IgG along the 100-measurement 
experiment. This 100 cycles measurement study was conducted in 5 days. Measurement was 
active 24/7.  Only reagents (switchavidin and IgG) were changed between the days.  
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Figure 10. Ratio of IgG/switchavidin binding capacity along the 100-measurement 
experiment. The reason for the decrease in the injection 20 shall be related to a contemporary 
deviation in one flow channel. Result is still valid and it is included in the flow channel 
measurement average as well as in all the other measurements. 
The results indicate that stable binding of switchavidin was occurring and verification 
with IgG seemed to function rather well. Like shown in the results section 5.1-5.3, the 
assay design strategy enabled to accomplish information about different environmental 
factors and constant strain caused by continuous measurements and about how the 
aging process evolves as a function of time. Stable binding of switchavidin was proven 
to function with these biotinylated sensor slides and verification with IgG seemed to 
function well. Additionally, aliquots were successfully made and stored.  
5.3 Regeneration and baseline change 
The regeneration evaluation was supported by the baseline change analysis as 
demonstrated in the Figure 4. The data obtained indicate that the layer formed on the 
biotinylated biosensor consisting of biotinylated IgG and switchavidin is removed 
successfully after each measurement cycle (Figure 12). Fortunately, it seems that 
almost complete repeated removal of all the protein molecules was achieved with some 
of the biotinylated sensor slides during the measurement. Figure 12 is demonstrating 
the sensor slide that is performing multiple cycles of binding and removal 
events. Regeneration was found to be complete. As a consequence, it would be 
interesting to make even longer measurements i.e. to include more days to the 
measurement protocol to evaluate the regeneration ability over extended time period. 
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Alternatively, studies in more comprehensive set of storage conditions with different 
humid conditions would be beneficial.  Such research would require lots of reagents, 
time and possible additional measurement devices.  
The results provide basement for further research in the sensor manufacturing and 
storage. One part of this research was focused mostly on how storage conditions effect 
the sensor performance, while 100 cycles measurements were testing sensor slide’s 
performance during the constant rigorous regeneration cycles. As rationalized in the 
literature of review, Figure 1 and Figure 3 – Figure 4, the quantitative dissociation of 
the biotin–switchavidin–biotin bridges from the surface of the sensor is occurred in the 
regeneration. In this Master’s Thesis, reproducibility of chip regeneration was studied. 
The recovery of these biotinylated sensor slide after fresh switchavidin and IgG 
injections can be successful if the storage environment have been optimal as results in 
the 5.1 - 5.3 are demonstrating. 
Like mentioned in the introduction, one of the main goals was to research the 
regeneration ability. As Knoglinger et al. (2018) have written in their article, 
regeneration protocols for sensor slides are useful only if the complete regeneration is 
occurring fast enough. Likewise, in this research, the regeneration phase for sensor 
slides was executed only for a few minutes. For this reason, the good regeneration 
performance obtained in such short time scale is indicating good regeneration 
performance. Results are indicating important further aspects where to concentrate in 
the follow-up studies. Neither citric acid 2.5% + SDS 0.25% nor SDS 0.5% alone are 
remarkably harming the surface of the sensor slide during the two weeks’ measurement 
cycles, though switchavidin and IgG are removed from the biotinylated surface. 
Indeed, the Figure 12 and Figure 3b are illustrating almost complete removal of 
switchavidin, without significant changes in baseline. Considering the strain caused to 
the sensor slides under measurements, results are indicating very good performance 
ability rather than collapse attributes. 
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Figure 11. Regeneration, +4°C and RT. Regeneration has been measured using two parallel 
sensors, and four measurement cycles were carried out during each day. (A) sensor stored at 
+4°C (B) sensor stored at RT. Please note that only one sensor was analyzed for the day 14 
for sensor stored at RT. Also, please note that the graphs are scaled differently as compared 
to those showing the measured binding data. 
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Figure 12. Regeneration, 100 cycles measurement. This 100 cycles measurement study was 
conducted in 5 days and measurement was active 24/7. Twenty measurement cycles were 
carried out during each day.  Only reagents (switchavidin and IgG) were changed between 
the days. 
As illustrated in Figure 11 and Figure 12, the baseline is often starting below zero and 
stabilizes only after few measurement cycles. This may demonstrate the recovery of 
the biotinylated sensor slide after storage. However, such a significant baseline drift 
was not seen in the subsequent cycles with sensor slide that was used in 100 cycles 
measurement. As the Figure 12 demonstrates, the baseline growth is relatively small 
(mDeg) and the change is beginning to increase slightly only after day 4 (i.e. after >50 
measurement cycles). 
The term sensor slide regeneration is illustrating that all bound injected molecules are 
removed from the sensor slide. This procedure is making biotinylated surface ready 
for the next injection of sample. This is why stability of sensor slide is important during 
removal. It was good choice to use regeneration buffer that have physiological ionic 
strength as Zauner et al. discussed in their work in 2016. Their regeneration 
experiments were made with sensor slides that were functionalized with avidin 
mutants (Zauner et al 2016). Results in the section 5.1-5.3 are indicating that 
regeneration can be done in reproducible manner if the sensor surface manufacturing 
is done with the right protocol and if the storage environment is optimal. SDS 0.5% is 
washing away the weakly bound materials from the sensor surface before the 
switchavidin injection. The phenomena can be seen also clearly before the first 
switchavidin injection in the Figure 1 (raw data), where the baseline in slightly dropped 
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after the SDS injection (1min – 10 min). Baseline have been changing relatively 
minimally between the injections in the 100 cycles measurement, even though the 
sensor slide has mots probably experienced lots of physical and chemical strain during 
the measurement cycles. However, the first injection with SDS is causing change of 
the baseline which is indicating that there have been proteins or other impurities 
adsorbed on the sensor slides’ surface.  
Based on the information provided in the literature review, biotin and switchavidin are 
binding each other non-covalently on the sensor surface (Knoglinger et al. 2018; 
Taskinen et al. 2014; Zauner et al. 2016). Figure 1 is demonstrating the binding of 
switchavidin in different storage conditions. Yet, some deviation in the regeneration 
graphs can be seen. It is possible that all the non-covalently binding molecules have 
not been washed away after the SDS 0.5% and citric acid 2.5% + SDS 0.25% wash. 
There may also be a possibility that the biotin coating of the sensor slides is not 
homogenous enough. 
5.4 Sensor slide’s performance and aging process for shelf life estimations 
Performance and durability under specified storage conditions was demonstrated in 
5.1 - 5.3 and results show that if biotinylated sensors are stored in right environment, 
they can be used repeatedly. 100 cycles measurements and different environmental 
measurements are indicating lots of information about the rates when sensors are about 
to lose their performance. In 30 °C this occurs already between day 4 and day 8. 
Comparison of RT and RT humid is clearly indicating that humid conditions can 
lengthen the shelf life and to slow down the aging. In the future, further studies could 
be potentially improved by identifying more facts associated with shelf life. In 
addition, shelf life could be followed for additional years. For example, follow up can 
be executed with the sensor slides used in this study. 
In summary, as the sensor ages the decrease in sensor binding capacity appears to 
accelerate (Figure 12). In a normal use, sensor slides can maintain their performance 
at least over two weeks in right conditions (Figure 5 – Figure 7). Specific shelf life of 
the biotinylated sensor slides’ can be studied further with these results and the sensor 
slides that were put in specific storage for further shelf life studies. This will give more 
information about specifications about how long sensor slide can performance well 
48 
 
 
after the immediate packaging is opened for the first time. Results are indicating that 
each sensor slide may have a different stability and shelf life due the different surface 
ratios which is why the manufacturing part of the sensor slides is really delicate and 
important. This may have to be pointed out in the future research.  
5.5 Value adds - Kit design   
One strategic decision is to create kits for specific customer needs as discussed in the 
review of literature. There are different features that can be highlighted already in the 
design phase. The kit is creating value for the customer needs. Basically, the kit saves 
customers time because it includes materials and reagents with instructions. Customer 
who uses the instruments from specific company could also buy custom made kits and 
repeat the purchases from this specific company. This requires high quality condition 
supply chain and logistics from the company. For example, customer from the 
Switzerland’s pharmaceutical industry can buy the customized kits for their device and 
final costs for the customer are defined based on the reagents and the materials needed 
for the kit. Multiple purchases can reduce the total costs. Marketing and strategy 
planning could be created based on the different segments in the customer base. For 
example, pharmaceutical industry, and food safety industry. Under these main 
categories there could be target segments for new customers and the key customers. 
The core of the kit is the specific amount of the sensor slides with the specific surface 
chemistry. It includes specifications also about different environments as results 5.1 – 
5.3 are demonstrating. 
The company’s product portfolio combined to the customized kits can bring relevant 
competitive advantage and more revenues for the company. Furthermore, it creates 
more assets to maintain and create stronger customer relationships. Additionally, the 
customer definition needs to be specific. Is customer the one who is buying the product 
or using the product? In some cases, customer can be the end-user or the supplier, 
depending on the context. For example; if a diagnostic biosensor has been developed 
for therapeutics, it can help both clinicians and patient. Revenues for the company are 
coming from the specific cluster, who eventually are buying the product. Nevertheless, 
the company needs the feedback from both clinicians and patients in order to gain 
comprehensive information to improve the products and the marketing strategies.  
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6 DISCUSSION 
6.1 Sensor slides 
In this study, switchavidin association on the biotinylated gold coated sensor slides 
exposed to variable environments was studied. Additionally, evidence emerged of 
sensor performance in relation with measurement days (storage time). Examination 
with the biotinylated gold coated sensor slides built the knowledge about the 
regeneration possibilities and understanding for the further research was gained. As 
the 100 cycles measurement shows (Figure 8 and Figure 12), the dissociation of 
switchavidin from the biotinylated surfaces as a function of time was remaining 
significantly robust during the whole measurement. Multiple analyses with 
switchavidin yielded similar results to Knoglinger et al. (2018), Taskinen et al. and 
(2014) Zauner et al. (2016) as avidin and it mutants being one of the optimal tools for 
biosensor related studies. As Knoglinger et al. (2018) are pointing out in their research, 
the major difficulties have been finding a method for switching off the robust bond 
between streptavidin and the biotin chip. Both Knoglinger et al. (2018) and Zauner et 
al. (2016) have been describing of wild-type streptavidin characteristics to remaining 
tetrameric in the presence of acid and SDS as in contrast to switchavidin mutants. In 
this study only switchavidin was used. Conversely avidin and streptavidin were mostly 
used in these above-mentioned studies. However, additional knowledge about 
biosensor related studies with switchavidin and biotinylated sensor slide’s 
performance was built in this thesis.  
The findings agree with several the other studies as sensor slide functionalization being 
one of the most important part of the biosensor related studies (Taskinen et al. 2014; 
Zauner et al. 2016). For example, some minor differences between sensor 1 and sensor 
2 are indicating that the functionalization might have been not as even i.e. homogenous 
as possible. In environment +4 °C, sensor 2 have slightly higher values than sensor 
slide 1 expect in day 10 (Figure 3 – Figure 5). The average for the flow channels was 
calculated in order to minimize the bias that could have occurred if only one flow 
channel was observed for the analyzes. However, additional error data analysis with 
different channels could give more specific information about the data. Average 
calculation was a good choice for data analyzation, rather than choosing just a one 
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flow channel. However, further information about channel differences might have 
been interesting to research and analyze. Yet, mDeg changes are easy to interpret as in 
a function of days and different environmental effects are readable. 
Assay design was succeeded even though some preference had to be made because 
there was only a limited timescale for the measurements due the parallel multiple 
measurements with exact timing. With two devices, the execution might have been 
more fluent. Multitude of ovens for multiple environments of stability and 
performance research could have been tested but the disadvantage of this approach 
was that one oven is dedicated to a single experimental set. Next step could be to have 
multiple ovens that in turn requires a more facilities and time frame to execute 
experiments because of the exact measurement timing of sensor slides as a function of 
time. 
One of the most interesting findings is that results in the RT Humid environment are 
indicating that optimal storage conditions of the gold coated and biotinylated sensor 
slides needs humidity (Figure 3 - Figure 5). One of the strength of the study included 
the 100 cycles measurement that especially indicates promising results for the 
regeneration performance.  As Vigneshvar et al. (2016) mentioned, regeneration can 
cause challenges in the field of biosensor related technology. Some unnecessary 
drifting in the early phase of the measurement can be caused by the lack of a dummy 
injection that Zauner et al. (2016) descried to be performed with regeneration buffer 
before starting repeated binding measurements. Even though reagents were placed 
early in the right temperature with the device before starting the measurement, 
discontinuity in the temperature dependence was observed at some time points. 
Biosensor are highly sensitive devices and as Bates (1962) already observed decades 
ago, temperature changes can change the pH of a solution even with buffers present 
(Bates 1962). Even though hellmanex washes were made, it is not excluded that cross 
contaminations incipient impurities could have occurred during the measurements 
because many people were using the device with different reagents.  
According the relative humidity changes as a function of temperature, it would be 
interesting to see whether variance in humidity correlates with different temperatures 
and affects to the sensor slide’s properties and performance. Additionally, according 
to the results, humidity shall have some positive impact on the storage conditions. The 
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phenomena could be further studied and discussed in the future studies. Further 
analysis about prediction of stability in packaged product is still needed but the results 
of are indicating the main points worth of focusing on. In the future shelf life and aging 
tests could be executed by controlled standard test methods. One additional measure 
of sensor slide’s product stability could be the color and surface change analyze. With 
atomic force microscopy (AFM) some differences between the sensors could be taken 
into account and analyzed during the measurements. Additional shelf life estimations 
based on the observed rate of the changes could be made as a function of time. 
6.2 Biosensors and market perspectives 
Besides the scientific biotechnological studies with MP-SPR, business aspects were 
highlighted through the thesis because biosensor related technology is very wide and 
has promising future perspectives. Global market research results are indicating 
significant areas where to concentrate and how to build strategic planning intelligently 
further (Grand View Research 2017). Strategic competitive related planning is needed 
to strengthen the equity, also in the biosensor related markets in order to gain more 
profits. New competitive marketplaces are emerging in the biotech field. Company can 
create significant acts of implicating in order to shape the customer’s brand choices. 
Biosensor markets are accelerating rapidly and this Master’s Thesis is suggesting that 
also smaller companies invest in consulting firms in order to make profound market 
research and in order to make business more profitable. Profound consulting assessment 
from different sectors of medicine, industry and technology can reduce business risks 
significantly. It is important to have knowledge to identify risks and key unknowns 
from different parts of the distinct market places (Dias 2014; Salazar et al. 2012). As 
discovered in the introduction, key account managers and engineers might have 
significantly different perspectives about product specifications and market research 
results can help to create more optimal solutions for complex problems. Unique 
features can have role in product life cycle evaluation and planning.  
Interest toward the new products and services is clearly existing and new revenues can 
be achieved also by developing services among other strategic planning as described in 
the review of literature (Vigneshvar et al. 2016; West et al. 2010; Wintjes 2006). The 
constant quality of sensor slides is essential. These results indicate for significantly 
better regeneration achieving methods in the future markets. Results did show 
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differences between sensor slides in the functional recovery levels. Via regeneration 
process improvements, significant competitive advantage can be achieved. This Master´s 
Thesis work is indicating that even more competitive advantage could be achieved by 
developing e.g. kit products further while improving some of the features in the existing 
devices. Besides product development, segmented strategies, marketing and selling 
messages should be created to the different customer sectors. 
On the basis of the market research, marketing should place strong input on the 
product. Especially in the new product development, pricing should be strongly 
influenced by marketing that has to play a strategic role. Green values, ethical and 
moral issues are namely important factors now days also in the field of business. Many 
companies have make a difference by owning green values to be an important part of 
a business plan e.g. in packaging (D’angelico et al. 2010). Strong service fundamentals 
and quick responds to challenges is needed to create value in the dynamic business 
world. Substantial growth and profit are created by attracting new customers and 
offering value propositions to their needs while responding to valid requirements of 
the key customers. Most successful solutions are often reflected of a diversity of 
multidisciplinary work than can lead to another benefit; opportunity for competitive 
differentiation (Dosi et al. 2015). By generating new ways to analyze data fast, 
biosensor companies can create a great cumulative advantage. Company can make a 
significant difference to other companies that are trying to appeal to the same 
customers by creating a value proposition and familiarity that is unique. Services have 
become significant value adds for the business, besides the actual product. More 
companies should offer profound scientific support to ensure compliance and assist 
with installation and software upgrades. Business transitions may take unexpected 
turns and key strategic questions needs great management skills. In the field of 
biosensor markets both substance knowledge and business intelligence are needed.  
Many companies are now investing to the digital supply chains and via that even new 
business models can be made. 
6.3 Sensor slide properties and business perspectives 
Many areas like drug research, clinical analysis, defense and environment research 
need the cost-effective solutions. Surface plasmon resonance biosensors are providing 
excellent analytical performance specs for precise use and various biosensors with the 
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diverse potential of usage creates very wide application possibilities. Furthermore, this 
creates more profit possibilities because the biosensors can be used in the field of drug 
discovery, biomedicine, security and defense. Food safety standards and 
environmental monitoring are also important examples about the imperative utilization 
of the biosensors (Dias 2014; Vigneshvar et al. 2016). Hence, diverse of various 
biosensors and customers makes the strategy planning challenging but it can bring new 
and fresh multidisciplinary benefits considering the future product development. 
Sensor slides were classified into four different groups based on the environments. 
This was a good indicator to evaluate the possible harms that are caused to the sensor 
slides by different storage conditions. Besides the storage conditions, the end user sites 
can vary a lot in terms of transport distance. Therefore, the results obtained here can 
be used to evaluate the optimal packaging, further shelf life research and storage 
environments from the very first time point when the sensor slides are manufactured. 
Information is necessary for the company but also for the customers. There are 
multiple ways to make business analyses to help to value the market size and growth 
prospects. Success requires quick capability to respond to customer needs and requests 
regarding all the products and services (Almquist et al. 2018, Bocken et al. 2014; 
Freeman and Beale 1992). Customers are willing to know how to use the sensor slides 
and instruments correctly in order to achieve the optimal sensor slide performance. 
Additionally, a holistic approach to a temperature controlled shipping can support to 
overcome the transportation obstacles and meet the regulatory requirements. Sensor 
slides that are reproducible and constant quality with the valid regeneration features 
would offer significant competitive advantage in the markets. 
Differences in functionality observed in between the sensor slides were slightly 
diverse, indicating that the surface chemistry properties could have been even more 
equal. Yet, range between parallel sensor slides analyzed in the same environment 
were varying expectedly less than that observed between different storage conditions. 
Nevertheless, there were surprisingly wide differences between some parallel 
measurements. This can be seen from the results 5.1 – 5.3 where the parallel sensor 
slides may differ from each other at some time points quite markedly (Figure 3 - Figure 
5). Yet, this is a great finding for the manufacturing department in order to make some 
adjustments. Additionally, it was noticed that the functionalization of the sensor slide 
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is better as the slides are made using fresh reagents. Both systematic and random errors 
may have occurred during and between the measurements. Many people were working 
in the same laboratory and the device was also used by other people. There are likely 
some biases that have been affecting to the results, even though work was really 
accurately and carefully executed. However, biases have been occurred mostly from 
the functionalization of the sensor slides, rather than working conditions. These 
findings can offer several practical implications for further studies. As described in the 
review of literature, in order to have meaningful market value, the satisfactory results 
are not good enough (Schwab 2017; Teece DJ 2010; Wirtz et al. 2016). First, company 
needs to have tools to identify profitability improvements to make better results. 
Second, recognizing the product problems in the early phase and diagnosing what 
changes are needed to achieve the right solution are important to consider. Third, it 
shows business intelligent to coordinate innovations strategically in order to bring 
more assets and value for the company. 
Sensor slides that are reproducible and constant quality with valid regeneration 
features would offer significant competitive advantage in the markets. Surface 
chemistry of the sensor slides needs to be in excellent condition in order to gain 
relevant revenues from the markets. Customers are willing to know the facts about the 
products in order to make repeated purchases. Besides the substance knowledge, the 
business intelligence about sales and marketing are very essential assets. Business 
model should include flexibility for new enhancements and innovations (Massa and 
Tucci 2013). This leads to the core question about what kind of risks the company can 
or have to take in order to be agile enough to outcome competitors? The right decision 
making requires powerful team with great management skills (Sveiby 1997; Wintjes 
2006). 
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7 CONCLUSIONS 
Possibility for repetitive measurement cycles with multiparametric surface plasmon 
resonance (MP-SPR) device can lower the research costs. Supporting the Knoglinger 
et al. (2018) and Zauner et al. (2016), it is necessary to eliminate sensor slide-to-sensor 
slide variation, which is a problem with some product lines. In this research, 
biotinylated sensor slides were found to be suitable for functionalization with 
switchavidin and they showed good performance in regeneration. When concerning 
all the results together at the end of the study period, sensor slide performance is 
generally starting to decrease after 12 days (Figure 3 – Figure 5). Further studies are 
needed to underline the specific days for different conditions.  
It was also found that the storage specifications of the sensor slides are important. The 
portfolio of the products and services defines the strategic lines besides the company’s 
awareness about the facts how the customer needs are met. Besides other aspects, the 
research is valid as Zauner et al. 2016 discussed about the importance of reagents and 
the sensor slide’s surface that must be stable under ambient conditions. 
The results are highlighting the fundamental importance of reagent choice and storage 
environment of the gold coated and biotinylated sensor slides that must be made with 
care, in order to exploit the full potential for regenerative biosensing. Results are 
supporting the findings Knoglinger et al. (2018) and Zauner et al. (2016) who showed 
that switchavidin is as an optimal tool for biosensor related applications. The 
accelerated and predictive performance and stability measurements can give insights 
for the future advances, needed in the field of accelerated aging methods for 
packaging, storage and sensor slide improvements. In addition, the main findings can 
aid to prevent unexpected instabilities in future researches and studies. Possible factors 
for instability were identified. Further research could identify if bigger number of 
sensors lose their performance ability at the same point of time as they are exposed to 
the exactly same environment for a prolonged time period. In conclusion, the 
experiments made in this research demonstrate that the regenerative gold coated 
biotinylated sensor slide is well suited for the reconstruction of the interaction 
mechanism between switchavidin and IgG. This study provides potential and cost-
56 
 
 
efficient approach to evaluate effects and costs of various biosensor related application 
possibilities on markets. Additionally, approach to improve sensor slide properties and 
functionalization further. 
Biosensors are associated with significant adverse applications and increased market 
potential. Value in the business markets is more than entity of the both technical, 
economical, service and social related benefits. As Schwab (2017) describes the 
complexity of the theory about fourth industrial revolution, biotech-related markets 
are growing and new solutions are constantly needed to meet the requirements of 
different customer segments. At the moment, in order to achieve and maintain 
competitive advantage, multiple companies still need employees and management 
with both business and technological substance intelligence combined to a capability 
for emotional intelligence. Managing flexible market offerings successfully is a part 
of company’s ability gain more revenues. Because of these extensive causal-
connections, this Master’s Thesis successfully underlined the value of 
multidisciplinary skills in order to push understanding and innovations further.  
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